Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ian McGovern"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 371-379 (2024)
ABSTRACTBackground Cell-based quadrivalent inactivated influenza vaccines (IIV4c) avoid egg-adaptive mutations found in egg-based production, improving vaccine effectiveness (VE). Studies demonstrate improved VE for IIV4c relative to egg-based quadri
Externí odkaz:
https://doaj.org/article/807c4c3d596840628d18191334031f74
Autor:
Ian McGovern, Benjamin Chastek, Tim Bancroft, Noah Webb, Mahrukh Imran, Stephen I. Pelton, Mendel D.M. Haag
Publikováno v:
International Journal of Infectious Diseases, Vol 146, Iss , Pp 107160- (2024)
Objectives: This study evaluated relative vaccine effectiveness (rVE) of MF59-adjuvanted trivalent inactivated influenza vaccine (aTIV) vs high-dose trivalent inactivated influenza vaccine (HD-TIV) for prevention of test-confirmed influenza emergency
Externí odkaz:
https://doaj.org/article/ba74f04987d645e59bb10f9679ce77ec
Autor:
Marco Del Riccio, Saverio Caini, Guglielmo Bonaccorsi, Chiara Lorini, John Paget, Koos van der Velden, Adam Meijer, Mendel Haag, Ian McGovern, Patrizio Zanobini
Publikováno v:
International Journal of Infectious Diseases, Vol 144, Iss , Pp 107052- (2024)
Objectives: The COVID-19 pandemic significantly changed respiratory viruses’ epidemiology due to non-pharmaceutical interventions and possible viral interactions. This study investigates whether the circulation patterns of respiratory viruses have
Externí odkaz:
https://doaj.org/article/b2c5ebb9e6e34d7b953dfabd7afe0b02
Publikováno v:
Vaccines, Vol 12, Iss 2, p 216 (2024)
Recommending co-administration of influenza and COVID-19 vaccines has emerged as a strategy to enhance vaccination coverage. This study describes the policy on co-administration and uptake of influenza and COVID-19 vaccination in Europe, the United K
Externí odkaz:
https://doaj.org/article/5cde3ff01f03477fbd5598939cea7e32
Autor:
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1839 (2023)
The authors would like to make the following corrections to this published paper [...]
Externí odkaz:
https://doaj.org/article/4ae67c62f3c44de0b1fd72841db9624b
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1607 (2023)
Cell-based seasonal influenza vaccine viruses may more closely match recommended vaccine strains than egg-based options. We sought to evaluate the effectiveness of seasonal cell-based quadrivalent influenza vaccine (QIVc), as reported in the publishe
Externí odkaz:
https://doaj.org/article/5567806f99374895bb45e3b578ec30e2
Autor:
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Publikováno v:
Vaccines, Vol 11, Iss 1, p 52 (2022)
To ensure that vaccination offers the best protection against an infectious disease, sequence identity between the vaccine and the circulating strain is paramount. During replication of nucleic acid, random mutations occur due to the level of polymer
Externí odkaz:
https://doaj.org/article/3e997f1cefeb458ba80f2ab02e2d28b2
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1610 (2022)
The COVID-19 pandemic, along with disruptions to routine medical care, brought renewed urgency to public health messaging about the importance of influenza vaccination. This retrospective cohort study used a database of linked claims and electronic m
Externí odkaz:
https://doaj.org/article/c2cab00c7a904bf2b7cc15acdcdbbd5a
Autor:
Analía Urueña, Paula Micone, María Cecilia Magneres, Ian McGovern, Joaquin Mould-Quevedo, Túlio Tadeu Rocha Sarmento, Norberto Giglio
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1627 (2022)
Background: Quadrivalent cell-based influenza vaccines (QIVc) avoid egg-adaptive mutations and can be more effective than traditional quadrivalent egg-based influenza vaccines (QIVe). This analysis compared the cost-effectiveness of QIVc and QIVe in
Externí odkaz:
https://doaj.org/article/30a62102180f4464b0fe1681a4d403ab
Autor:
Constantina Boikos, Ian McGovern, Justin R. Ortiz, Joan Puig-Barberà, Eve Versage, Mendel Haag
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1456 (2022)
Traditional influenza vaccines may be less immunogenic in adults ≥65 years of age due to immunosenescence. Two influenza vaccines—MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose influenza vaccine (HD-IIV3)—were d
Externí odkaz:
https://doaj.org/article/2b74e9a65d594cbb8bd95b40ec903a00